| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/28/2010 | EP2209528A1 Rapid acting injectable insulin compositions |
| 07/28/2010 | EP2209498A2 Treatment of proliferative disorders using antibodies to psma |
| 07/28/2010 | EP2209493A2 Compositions comprising sphingosine 1 phosphate (s1p) receptor modulators |
| 07/28/2010 | EP2209469A2 Beta adrenergic receptor agonists for treatment of pain and/or inflammation |
| 07/28/2010 | EP2209466A2 Methods and compositions for treating post-operative pain comprising clonidine |
| 07/28/2010 | EP2209465A1 Oral composition comprising a cooling agent |
| 07/28/2010 | EP2209464A1 Anti-malarial pharmaceutical composition |
| 07/28/2010 | EP1996237B1 Method for making polyethylene glycol carbonates |
| 07/28/2010 | EP1432403B1 Liposome loading with metal ions |
| 07/28/2010 | CN1767819B Solid pharmaceutical compositions comprising a S1P receptor agonist and a sugar alcohol |
| 07/28/2010 | CN1625409B Immunogen preparation of variable peptidic epitopes and preparation method thereof |
| 07/28/2010 | CN101790541A High-amylose sodium carboxymethyl starch sustained release excipient and process for preparing the same |
| 07/28/2010 | CN101790387A Radiopharmaceutical composition |
| 07/28/2010 | CN101790385A Molecules for targeting compounds to various selected organs, tissues or tumor cells |
| 07/28/2010 | CN101787120A Triblock polyamino acid and hydrogel thereof |
| 07/28/2010 | CN101787119A Polymer with tumor organization pH responsiveness and micelle thereof |
| 07/28/2010 | CN101787117A Preparation method and application of polyethylene glycol-polysialic acid block copolymers |
| 07/28/2010 | CN101787062A Hesperetin dihydrochalcone-7-O-glucoside and preparation method and application thereof |
| 07/28/2010 | CN101787059A Method for preparing digalactosyl diacylglycerol and application thereof |
| 07/28/2010 | CN101786601A Preparation method of compound nano particle with Fe3O4/CoO core shell structure |
| 07/28/2010 | CN101785867A Preparation method of corn protein nano-particles |
| 07/28/2010 | CN101785866A Preparation method of d-alpha-tocopheryl succinate monoester biomembrane covering |
| 07/28/2010 | CN101785865A pH response type amphipathic stem-grafting polyphosphazenes feeding micelle and preparation method thereof |
| 07/28/2010 | CN101785864A Post-crosslinking hydrophilic patch substrate and preparation method thereof |
| 07/28/2010 | CN101785863A Gel-forming composition |
| 07/28/2010 | CN101785862A Infrared light triggering controllable drug carrier and preparation method thereof based on up-conversion material |
| 07/28/2010 | CN101785861A Injectable compositions for the controlled delivery of pharmacologically active compound |
| 07/28/2010 | CN101785860A Tegafur/layered duplex metal hydroxide nanometer hybrid and preparation method thereof |
| 07/28/2010 | CN101785830A Antibacterial agent and antibacterial composition |
| 07/28/2010 | CN101785794A Pharmaceutical composite and application thereof |
| 07/28/2010 | CN101785784A Compound of gold nanorods and zwitter ion molecules for photo-thermal therapy of cancer and preparation method thereof |
| 07/28/2010 | CN101785782A Long-circulating ligustrazine composite injection and preparation method thereof |
| 07/28/2010 | CN101785769A Solid pharmaceutical formulations comprising telmisartan |
| 07/28/2010 | CN101785766A Lidocaine and chlorhexidine aerosol |
| 07/28/2010 | CN101785764A Method for improving blood compatibility of microcapsule |
| 07/28/2010 | CN101785763A Metformin hydrochloride enteric-coated sustained release tablet and preparation method thereof |
| 07/28/2010 | CN101785761A Compound hemostasis medicine and preparation method thereof |
| 07/28/2010 | CN101785760A Spontaneously-combined chitosan medicine-carrying nano particle and preparation method thereof |
| 07/28/2010 | CN101785759A Nanoparticle for embedding medicinal Adriamycin as well as preparation method and application thereof |
| 07/28/2010 | CN101785758A Cefmenoxime hydrochloride/anhydrous sodium carbonate pharmaceutical composition liposome injection |
| 07/28/2010 | CN101785757A Taxol self-emulsifying preparation, preparation method and purpose thereof |
| 07/28/2010 | CN101785756A Celtezole sodium suspension preparation and novel application thereof |
| 07/28/2010 | CN101785754A Intravenous drug delivery system for ibuprofen and preparation method thereof |
| 07/28/2010 | CN101785753A Gastrodia elata genin transdermal gel for central nervous system disease treatment |
| 07/28/2010 | CN101785477A Polyoxyethylene nonyl phenyl ether iodine complex disinfecting solution and preparation method thereof |
| 07/28/2010 | CN101357990B Tadpole polymer with controllable molecular weight and good biocompatibility and preparation method thereof |
| 07/28/2010 | CN101337994B Starch acetate/PPDO-grafted copolymer, preparation method and application thereof |
| 07/28/2010 | CN101283985B Enteric oral vaccine for fishing gear and preparation method thereof |
| 07/28/2010 | CN101249069B Tilmicosin long-acting injection and method of preparing the same |
| 07/28/2010 | CN101199480B Compounded propofol fat emulsion injection containing analgesics and process for preparing same |
| 07/28/2010 | CN101185650B Penciclovir ophthalmic temperature sensitivity in situ gel preparation and preparation method thereof |
| 07/28/2010 | CN101057861B Polycarbophil enteric coated medicinal composition |
| 07/28/2010 | CN101015565B Vaginal abluent |
| 07/27/2010 | US7764992 Method of esophageal function testing with a standardized thixotropic swallow challenge medium |
| 07/27/2010 | US7763718 Free of transmembrane domain; immunoglobulins; autoimmune diseases |
| 07/27/2010 | US7763712 Bone delivery conjugates and method of using same to target proteins to bone |
| 07/27/2010 | US7763663 Polysaccharide-containing block copolymer particles and uses thereof |
| 07/27/2010 | US7763631 substituted amino pyrimidine derivatives useful in the treatment or prevention of viral infections, in particular against human immunodeficiency virus (HIV), which is the aetiological agent of acquired immune deficiency syndrome (AIDS) in humans |
| 07/27/2010 | US7763603 Manipulation of brain CDP-diacylglycerol and uses thereof |
| 07/27/2010 | US7763434 monoclonal antibodies against interleukin-15(IL-15) that prevent IL-15 from effecting signal transduction through the beta - or gamma -subunits of the IL-15 receptor complex; treating transplant rejection and graft-versus-host disease |
| 07/27/2010 | US7763286 Composition comprising an extract of Tiarella polyphylla and tiarellic acid isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity |
| 07/27/2010 | US7763278 As cholesterol lowering agents and for treatment of cardiovascular disorders |
| 07/27/2010 | US7763277 drug delivering phosphorous or a platinum anti-cancer substance through an implant comprising a resorbable mesoporous silicon carrier material; biodegradable; administering micronutrient, or trace elements or minerals |
| 07/27/2010 | US7763276 Chewable soft capsules having improved administration properties and process for producing the same |
| 07/27/2010 | US7763275 Nanocapsules having a polyelectrolyte envelope |
| 07/27/2010 | US7763274 Carrier matrix having open pores or capillary spaces serving as liquid reservoir; does not require uniform distribution |
| 07/27/2010 | US7763269 generating and delivering foam simultaneously using a syringe based device; comprises a sclerosant liquid, polidocanol solution, and gas N2, O2 or CO2; by inter alia causing a localised inflammatory reaction, favor the elimination of varicose veins and other disorders involving venous malformation |
| 07/27/2010 | US7763248 Humanized collagen antibodies and related methods |
| 07/27/2010 | US7763247 Humanized collagen antibodies and related methods |
| 07/27/2010 | US7763234 peptides drugs that are converted into its active form, by cleavage by angiotensin converting enzyme in vivo, for use in the treatment and diagnosis of congestive heart failure, cardiac arrhythmia and other diseases where fibrosis is prominent |
| 07/27/2010 | CA2475025C Solid composition for oral or rectal administration having a melting point of 25.degree.c or higher and comprising a mixture of polar glycolipids and non-polar lipids |
| 07/27/2010 | CA2457034C Ophthalmic composition comprising an ascomycin |
| 07/27/2010 | CA2448456C Solid pharmaceutical formulations comprising modafinil |
| 07/27/2010 | CA2448319C Cytotoxins, prodrugs, linkers and stabilizers useful therefor |
| 07/27/2010 | CA2444266C Use of bile acid or bile salt fatty acid conjugates |
| 07/27/2010 | CA2435425C A suspension comprising fibrinogen, thrombin and alcohol, a method for preparing such a suspension, a method for coating a carrier with such a suspension, a method of drying a coating of a carrier, and a coated collagen sponge |
| 07/27/2010 | CA2419429C Elastomeric functional biodegradable copolyester amides and copolyester urethanes |
| 07/27/2010 | CA2408915C Self-emulsifying active substance formulation and use of this formulation |
| 07/27/2010 | CA2384717C Topical treatment for prevention of ocular infections |
| 07/27/2010 | CA2231801C Conjugates of a polypeptide and a biocompatible polymer |
| 07/22/2010 | WO2010083439A2 Recombinant human albumin-human granulocyte colony stimulating factor for the prevention of neutropenia |
| 07/22/2010 | WO2010083434A2 New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor |
| 07/22/2010 | WO2010083154A2 Heterofunctional segment-poly(ethylene glycol) polymers as delivery vehicles |
| 07/22/2010 | WO2010083035A2 Transdermal administration of tamsulosin |
| 07/22/2010 | WO2010082863A1 Method and composition for treating multiple sclerosis (variants) |
| 07/22/2010 | WO2010082634A1 Compound retained in tumor |
| 07/22/2010 | WO2010082602A1 Process for producing o/w microemulsion preparation for external application |
| 07/22/2010 | WO2010082487A1 Oil-gelling agent comprising reverse worm-like micelles and thickened gel-like composition |
| 07/22/2010 | WO2010081984A1 Formulation for oral transmucosal administration of analgesic and/or antispasmodic molecules |
| 07/22/2010 | WO2010081824A2 Active coating of pharmaceutical dosage forms |
| 07/22/2010 | WO2010081800A2 New pharmaceutical compositions |
| 07/22/2010 | WO2010081787A1 IMPROVED TNFα ANTAGONISM, PROPHYLAXIS & THERAPY WITH REDUCED ORGAN NECROSIS |
| 07/22/2010 | WO2010062854A3 Methods and compositions for using bleomycin-derivatized microbubbles |
| 07/22/2010 | WO2010057962A3 Crf conjugates with extended half-lives for use in inhibiting tumor progression |
| 07/22/2010 | WO2010053572A9 Aminoalcohol lipidoids and uses thereof |
| 07/22/2010 | WO2010047607A3 Method of production of polyanionic drug-carrier conjugates |
| 07/22/2010 | WO2010045506A3 Sustained drug delivery system |
| 07/22/2010 | WO2010045292A3 Nanoparticle compositions comprising liquid oil cores |
| 07/22/2010 | WO2010040772A3 Targeting construct comprising anti-polymer antibody and liposomes or microvesicles binding to the same |
| 07/22/2010 | WO2010039006A3 Method of manufacturing solid microstructure and solid microstructure manufactured based on same |